Clinical Trials Logo

Premature Birth clinical trials

View clinical trials related to Premature Birth.

Filter by:

NCT ID: NCT03587558 Recruiting - Clinical trials for Ventricular Premature Complexes

Effects of Carvedilol on Suppressing the Premature Ventricular Complex/Ventricular Tachycardia From Outflow Tract

FOREVER
Start date: September 5, 2017
Phase: Phase 4
Study type: Interventional

Carvedilol is known to be effective in reducing ventricular arrhythmias and mortality in patients with heart failure. It is suggested that one of the mechanisms is its ability to block store overload-induced Calcium release which activates spontaneous calcium release by Ryanodine receptors. Ventricular outflow tract tachyarrhythmia is known to be associated with calcium overload due to activation of Ryanodine receptors. The aim of this study is to evaluate the efficacy of Carvedilol on premature ventricular complex(PVC)/ventricular tachycardia(VT) originating from outflow tract.

NCT ID: NCT03583112 Recruiting - Clinical trials for Premature Ejaculation

Investigation of the Changes of Brain Structure and Function in Premature Ejaculation Patients and the Effects of Dapoxetine on Central Neural Activity in Premature Ejaculation Patients

Start date: July 10, 2018
Phase: N/A
Study type: Interventional

Lifelong premature ejaculation (LPE) is a common male sexual dysfunction with a high prevalence in global. Up to now, the etiology of LPE remains unclear. In recent years, dapoxetine, a highly potent serotonin-transporter inhibitor, has been used for treating premature ejaculation. However, the underlying mechanism of dapoxetine was unknown. Recently, with widespread use of neuroimaging techniques, like positron emission tomography and magnetic resonance imaging (MRI) in basic science, researchers can acquire human data on cerebral base of human sexual behavior, not only in normal subjects but also in patients with sexual dysfunction. Therefore, in order to further understand the biological mechanism of LPE and the brain targets of dapoxetine, the present study would investigate the brain changes of LPE and the effect of dapoxetine on brain activation by using MRI technology.

NCT ID: NCT03580252 Completed - Cerebral Palsy Clinical Trials

Reliability of Hammersmith Examination in Prediction of Neurological Outcomes (REHAPENO)

REHAPENO
Start date: March 1, 2018
Phase:
Study type: Observational

In this study workers are trying to test the correlation between Hammersmith Infant Neurological Examination and MRI brain/cranial ultrasound with early prediction of neurological developmental outcome of preterm neonates. This study is prospective cross-sectional collecting the data of patients according to daily standard medical practice

NCT ID: NCT03578783 Completed - Clinical trials for Premature Ejaculation

PSD502 in Subjects With Premature Ejaculation

Start date: December 26, 2018
Phase: Phase 2
Study type: Interventional

This study is being done to test the effect of PSD502 (the study medication) compared to placebo in subjects with premature ejaculation. PSD502 is a topical (applied to skin) anesthetic spray containing a mixture of two drugs called lidocaine and prilocaine that will be applied to the penis. Half of the subjects will receive PSD502 and half will receive placebo.

NCT ID: NCT03578341 Active, not recruiting - Clinical trials for Immune System Diseases

Oral Colostrum and Its Effect on Immune System

Start date: June 1, 2018
Phase: Phase 3
Study type: Interventional

The purpose of this project is to increase the serum immunological defenses of premature infants less then 32 weeks of gestation by administrating colostrum in the oropharyngeal mucosa versus placebo

NCT ID: NCT03577587 Completed - Clinical trials for Breast Milk Production

Efficacy of Herbal Galactagogue Silitidil After Preterm Birth

Start date: August 14, 2017
Phase: N/A
Study type: Interventional

After preterm birth mothers often suffer from hypogalactia. Herbal galactogogues can be used in order to increase milk production. In this double-blind, randomized, placebo-controlled clinical trial the effect of Silitidil, an extract from milk thistle, on the postpartal milk production in mothers of very premature newborns is investigated.

NCT ID: NCT03574766 Completed - Anxiety Clinical Trials

Meditation for NICU Moms

Start date: October 17, 2018
Phase: N/A
Study type: Interventional

This project explores whether meditation increases breastmilk supply in mothers who are pumping milk for infants in the NICU. Mothers will be randomly assigned to daily meditation while pumping using an app designed for meditation for new mothers, and their breastmilk volume will be measured after one week of meditation versus a control group with measurements at the same time points. Investigators will also determine whether mediation improves breastfeeding confidence and reduces stress, anxiety and depression symptoms in these mothers. Finally investigators will examine the effect on salivary cortisol levels.

NCT ID: NCT03574350 Completed - Preterm Infant Clinical Trials

Effect on Early Somatic Growth of a Daily Kinesthetic Stimulation on Preterm Infants

KISONKAP
Start date: August 15, 2013
Phase: N/A
Study type: Interventional

Kangaroo position (KP), the essential component of the Kangaroo Mother Care (KMC) method, has been increasingly implemented, given the benefits of early skin-to-skin contact on the cerebral maturation of preterm infants. In addition it allows for parents to bond with their infants and humanize the care of fragile infants in neonatal units. Evidence on kinesthetic stimulation (KS) is scarce and currently there is no available evidence on KS during the KP. KS is associated with massage in this paper

NCT ID: NCT03570294 Completed - Premature Birth Clinical Trials

Oxidative Stress in Women Treated With Atosiban for Impending Preterm Birth

Start date: February 1, 2014
Phase: N/A
Study type: Interventional

Oxidative stress is recognized as a important factor in the pathogenesis premature birth. Preterm birth is defined as delivery before 37 completed weeks of gestation and it is the leading cause of neonatal morbidity and mortality. The investigators conducted this analysis to investigate the safety of administration of Atosiban - a reversible, competitive antagonist of the oxytocin receptor in the treatment of preterm labor and its impact on the level of oxidative stress after 48 hours of tocolytic treatment.

NCT ID: NCT03565874 Completed - Anxiety Clinical Trials

Heart Rate Variability and Prematurity

Start date: June 12, 2018
Phase: N/A
Study type: Interventional

Mothers who deliver prematurely (<37 weeks of gestational age) experience intense stress and anxiety given that their child's survival and development might be compromised. From the existing literature, it is known that a heart rate variability biofeedback (HRVB) program increases heart rate variability (HRV), which in turn, is related to significant reductions in perceived stress and anxiety. This study's aim is to evaluate the feasibility of an HRVB program in a sample of mothers who delivered prematurely.